Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis

Dermatology

Volumn 215, Issue 2, 2007, Pages 134-138

  Sand, Michael ^a,c   Bechara, Falk G ^a   Sand, Daniel ^b   Radenhausen, Michael ^a   Tomi, Nordwig S ^a   Altmeyer, Peter ^a   Hoffmann, Klaus ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Atopic dermatitis; Extracorporeal photopheresis; Photochemotherapy

Indexed keywords

ANTIHISTAMINIC AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; HYDROCORTISONE; METHOXSALEN; STEROID; UNCLASSIFIED DRUG; UVADEX;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; DRUG SAFETY; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT INVENTORY; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; QUALITY OF LIFE; SHORT FORM 36; SKIN MANIFESTATION; TREATMENT DURATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

CHRONIC DISEASE; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; METHOXSALEN; MIDDLE AGED; PHOTOPHERESIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 34547802741     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104265     Document Type: Article

References (15)

1. Furue M, Koga T, Yamashita N: Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis. Br J Dermatol 1999;140:67-72.
2. Colver GB, Symons JA, Duff GW: Soluble interleukin 2 receptor in atopic eczema. BMJ 1998;298:1426-1427.
3. Schmitt J, Heese E, Wozel G, Meurer M: Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris - A prospective study. Dermatology 2007;214:68-76.
4. Grimalt R, Mengeaud V, Cambazard F: The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007;214:61-67.
5. Edelson R, Berger C, Gasparo F, et al: Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results. NEJM 1987;316:297-303.
6. Edelson R, Perez M, Heald P, Berger C: Extracorporeal photochemotherapy. Biol Ther Cancer Updates 1994;4:1-12.
7. Prinz B, Nachbar F, Plewig G: Treatment of severe atopic dermatitis with extracorporeal photopheresis. Arch Dermatol Res 1994;287:48-52.
8. Richter H, Billmann-Eberwein C, Grewe M, et al: Successful monotherapy of severe and intractable atopic dermatitis by photopheresis. J Am Acad Dermatol 1998;38:585-588.
9. Prinz B, Michelsen S, Pfeiffer C, Plewig G: Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis. J Am Acad Dermatol 1999;40:557-582.
10. Radenhausen M, Kobyletzki G, Hoxtermann S, et al: Activation markers in severe atopic dermatitis following extracorporeal photochemotherapy. Acta Derm Venereol 2003;83:49-50.
11. Abels C, Proksch E: Therapie des atopischen Ekzems. Hautarzt 2006;57:711-725.
12. Scheinfeld NS, Tutrone WD, Weinberg JM, DeLeo VA: Phototherapy of atopic dermatitis. Clin Dermatol 2003;21:241-248.
13. Simon D, Lubbe J, Wuthrich B, Wiesner A, Weber MM, Lafitte E, Anliker MD, Schoni MH, Braathen LR, Schmid-Grendelmeier P, Gilgen Bobalj N, Schneider D: Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice: analysis of a Swiss cohort. Dermatology 2006;213:313-318.
14. Yu FC, Gibbon GW, Klaustermeyer WB: Refractory atopic dermatitis treated with low dose cyclosporin. Ann Allergy Asthma Immunol 2002;89:127-131.
15. Radenhausen M, Michelsen S, Plewig G, Bechara FG, Altmeyer P, Hoffmann K: Bicentre experience in the treatment of severe generalised atopic dermatitis with extracorporeal photochemotherapy. J Dermatol 2004;31:961-970.